Skip to main content
. 2018 Dec 18;9:5370. doi: 10.1038/s41467-018-07804-8

Fig. 2.

Fig. 2

Potency of drugs targeting the cyt-bc1:aa3 against M. ulcerans. a Growth inhibitory activity of Q203 and bedaquiline (BDQ) against classical M. ulcerans clinical isolates from Africa (blue symbols) and Australia (red symbols) replicating in culture broth medium using a resazurin-based assay. Data are expressed as the mean ± s.d. of triplicates for each concentration. b Growth inhibitory activity (MIC50) of Q203 and BDQ against classical strains from African and Australian origin, and against ancestral strains from Japanese origin. MIC50 values are the average of three strains, each tested in duplicate. c Growth inhibitory activity of Q203 and bedaquiline (BDQ) against the classical strain S1013 (red symbols) and the ancestral strain S1325 (blue symbols) replicating in culture broth medium using a turbidity-based assay. Data are expressed as the mean ± s.d. of triplicates for each concentration. The red dotted line shows the bottom plateau for the dose–response curve for bedaquiline and Q203 against the classical strain; the blue dotted line shows the bottom plateau of the dose–response curve for Q203 against the ancestral strain. d Bactericidal potency of Q203 against the classical strain S1013 replicating in culture broth medium. Q203 was tested at a concentration of 1, 4, and 16 nM in triplicate and repeated once. The dotted line represents the limit of detection. **P value <0.001, using the Student's t test, between the untreated control group (1% DMSO) and Q203 at either 1, 4 or 16 nM